CompanyDeals

CSPC Jushi Biopharm’s SYSA1801 ADC Secures Licensing Deal with Elevation Oncology

Policy / Regulatory

CDE Releases 61st Batch of Generic Reference Preparations, 34 New Specs Added

Company

Immunochina Pharmaceuticals Secures CAR-T Production License in Beijing

CompanyDeals

Kolo Medical Raises RMB 100M in Series B2 to Launch High-Frequency Ultrasound Imaging System

CompanyDrug

Nestle Launches China’s First Cancer-Focused FSMP Product Oral Impact Su Yi Su

CompanyDigital

Sanofi’s Hornstein Sees China’s Online Hospitals Boosting Digital Health Strategy

CompanyDrug

Nuance Pharma Initiates Phase I Study for Ketorolac IV Infusion (NTM-001)

CompanyDrug

Henlius Biotech’s HanBeiTai Biosimilar of Avastin Accepted for CDE Review

CompanyDeals

CStone Pharmaceuticals and Kindstar Global Partner on Blood Tumor Precision Diagnosis and Treatment

CompanyDeals

Wanbangde Pharmaceutical to Acquire Consun Pharma Shares in RMB 2.2B Deal

CompanyDrug

Brii Biosciences’ COVID-19 Antibody Cocktail Effective Against Omicron BA.4/5 and BA.2.12.1

CompanyDeals

CMS Acquires Wuhan YZY Biopharma’s Bispecific Antibody Assets for Fundus Disease